hadb4y55 | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Dal-R%C3%A9%2C_Rafael>
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.vaccine.2021.01.050>
?:doi	10.1016/j.vaccine.2021.01.050
?:journal	Vaccine
?:license	els-covid
?:pdf_json_files	document_parses/pdf_json/f83ec1f688bb04b739096ade912d495cb39eb418.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7817401>
?:pmid	<https://research.tib.eu/covid-19/entity/33516602.0>
?:pmid	33516602.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/f83ec1f688bb04b739096ade912d495cb39eb418>
?:source	Elsevier; Medline; PMC
?:title	US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2021-01-20

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/hadb4y55>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/hadb4y55>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all